Asian Pacific Journal of Health Sciences

Yazarlar: Rohit R Doke, Ajay A Bhagwat, Rahul P Lokhande

Konular:-

DOI:10.21276/apjhs.2020.7.2.10

Anahtar Kelimeler:COVID,9,Pathogenicity,SARS,OV2,Structure,Treatment strategies

Özet: The evolving coronavirus disease (COVID-19) spread across the world, affecting more than 200 countries and territories. The genomic analysis proposed that the COVID-19 virus first observed in bats and later spread to humans through unidentified intermediate hosts in the Wuhan Seafood Market, China, in December of 2019. COVID-19 belongs to the family of Beta coronavirus and also refers to severe acute respiratory syndrome coronavirus 2(SARS-CoV2) due to its genetic similarities with severe acute respiratory syndrome coronavirus (SARS-CoV- pandemic observed in 2003). At present no any promising treatment strategies or vaccine is available. Hence many researchers and physicians are studying existing agents for its use against COVID-19 infections. Although it provides only symptomatic relief, it helps to halt infection. The intention of this review article is to provide a brief summary of the origin, basic structure, pathogenicity, potent available therapeutic strategies against COVID-19 infection.’

---